Intentar ORO - Gratis
Retail catches a falling knife as NSE shares dive
Mint Mumbai
|September 25, 2025
Retail exposure may be overstated, shows NSE data, amid talks to replace weekly contracts with fortnightly or monthly tenures. reuters
Late entrants into the National Stock Exchange’s (NSE) unlisted shares have been singed by a steep correction in its stock price over the past two weeks, compounding losses since July’s record highs.
The fall has hurt retail shareholdersthe most, whose numbers quadrupled in the three months through June.
The selloffhas been driven by two concerns: marketregu-lator Sebi weighing the future of weekly index options contracts—Nifty and Sensex options—in light of the huge losses faced by individual investors, and diminished visi bility on NSE’s listing this fis cal year.
The prices of NSE’s unlisted shares have fallen 7.3% over the past two weeks to around ₹1,900-1,940 from ₹2,050 on 11 September, when Mint reported that the Securities and Exchange Board of India (Sebi) could soon issue a consultation paper on extending the tenure of index options contracts from weekly to pos sibly fortnightly.
Sebi’s concern stems from its latest study showing that the average loss of 8.7 million individual traders rose to ₹1.1 lakh in FY25 from 86,728 each in FY24, largely due to weekly options trading.
Esta historia es de la edición September 25, 2025 de Mint Mumbai.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Mint Mumbai
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

